A significant shift in our drug policy has happened, as the regulators permit the use of psilocybin mushrooms for therapeutic applications. Until now, these substances were strictly restricted, but a growing body of research suggests they could offer aid for mental health illnesses like anxiety. The new policy represents a key step toward rethinkin